12 Health Care Stocks Moving In Wednesday's Pre-Market Session

+0.62%

-2.90%

-3.23%

+10.92%

Delist

Acrivon Therapeutics, Inc. ACRV	1.62	+0.62%
Akanda Corp AKAN	0.82	-2.90%
Can-Fite BioPharma Ltd. Sponsored ADR CANF	3.60	-3.23%
Citius Pharmaceuticals Inc CTXR	0.96	+10.92%
Dynavax Technologies Corporation DVAX	15.50	Delist

Gainers

Indaptus Therapeutics (NASDAQ:INDP) stock rose 63.6% to $3.19 during Wednesday's pre-market session. The company's market cap stands at $3.4 million.
Dynavax Technologies (NASDAQ:DVAX) stock moved upwards by 38.0% to $15.36. The company's market cap stands at $1.3 billion.
Citius Pharmaceuticals (NASDAQ:CTXR) stock increased by 16.34% to $1.21. The market value of their outstanding shares is at $19.2 million. The company's, Q4 earnings came out yesterday.
Omeros (NASDAQ:OMER) stock increased by 14.28% to $10.0. The company's market cap stands at $620.3 million.
Repare Therapeutics (NASDAQ:RPTX) shares moved upwards by 13.36% to $2.46. The company's market cap stands at $93.2 million.
OneMedNet (NASDAQ:ONMD) stock rose 8.13% to $1.4. The market value of their outstanding shares is at $65.7 million.

Losers

Can Fite Biofarma (AMEX:CANF) stock fell 21.8% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.1 million.
Femasys (NASDAQ:FEMY) stock declined by 10.64% to $0.71. The company's market cap stands at $46.7 million.
EUDA Health Holdings (NASDAQ:EUDA) stock declined by 9.38% to $1.74. The market value of their outstanding shares is at $72.5 million.
Minerva Neurosciences (NASDAQ:NERV) stock decreased by 6.16% to $3.81. The company's market cap stands at $28.3 million.
Acrivon Therapeutics (NASDAQ:ACRV) shares fell 5.61% to $2.19. The market value of their outstanding shares is at $73.2 million.
Akanda (NASDAQ:AKAN) shares fell 5.46% to $0.53. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.